Omrix Biopharmaceuticals News
Most Popular Omrix Biopharmaceuticals Story
King, J&J announce big buyouts
Two big deals hit the papers today: King Pharmaceuticals is taking over Alpharma, and Johnson & Johnson has inked an agreement to buy Omrix. Together they amount to more than $2 billion in Read more...
Latest Headlines
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
